Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.770
0.00 (0.00%)
At close: Mar 6, 2026, 4:00 PM EST
2.760
-0.010 (-0.36%)
After-hours: Mar 6, 2026, 5:19 PM EST

Cellectar Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
12.5523.299.5619.8735.757.17
Cash & Short-Term Investments
12.5523.299.5619.8735.757.17
Cash Growth
-63.36%143.48%-51.85%-44.36%-37.54%438.55%
Other Current Assets
1.070.960.890.660.870.77
Total Current Assets
13.6224.2510.4520.5336.5757.94
Net Property, Plant & Equipment
0.981.21.590.980.550.64
Other Long-Term Assets
0.030.030.030.080.080.08
Total Assets
14.6325.4712.0821.5937.258.66
Accounts Payable
4.017.599.185.483.853.44
Current Portion of Leases
0.10.080.060.050.140.12
Other Current Liabilities
0.81.7216.125.97--
Total Current Liabilities
4.919.3925.3611.53.993.56
Long-Term Leases
0.340.410.490.550.170.3
Total Long-Term Liabilities
0.340.410.490.550.170.3
Total Liabilities
5.259.825.8512.054.163.86
Preferred Stock
0.520.524.68-1.3820.04
Common Stock
000000
Additional Paid-in Capital
271.31261.12182.92168.14182.56161.53
Retained Earnings
-263.84-247.34-202.76-159.99-150.9-126.78
Total Common Shareholders' Equity
814.29-15.168.1533.0554.79
Minority Interest
1.381.381.381.38--
Shareholders' Equity
9.3815.68-13.789.5433.0554.79
Total Liabilities & Equity
14.6325.4712.0821.5937.258.66
Total Debt
0.430.490.550.60.30.42
Net Cash (Debt)
12.1222.799.0119.2635.456.74
Net Cash Growth
-46.82%152.94%-53.22%-45.59%-37.61%462.53%
Net Cash Per Share
6.2918.4122.1281.90191.31859.20
Book Value
814.29-15.168.1533.0554.79
Book Value Per Share
4.1511.55-37.2134.67178.57829.69
Tangible Book Value
814.29-15.168.1533.0554.79
Tangible Book Value Per Share
4.1511.55-37.2134.67178.57829.69
Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q